This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacKenzie, C. J. Articles by Mitchell, R. Search for Related Content PubMed PubMed Citation Articles by MacKenzie, C. J. Articles by Mitchell, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL

Mechanisms of Phospholipase C Activation by the Vasoactive Intestinal Polypeptide/Pituitary Adenylate Cyclase-Activating Polypeptide Type 2 Receptor

Medical Research Council Membrane and Adapter Proteins Co-operative Group, Membrane Biology Group, Department of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom EH8 9XD; and Medical Research Council Brain Metabolism Unit, Edinburgh, United Kingdom EH8 9JZ

Address all correspondence and requests for reprints to: Dr. R. Mitchell, Medical Research Council Membrane and Adapter Proteins Co-operative Group, Membrane Biology Group, Department of Biomedical Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, United Kingdom EH8 9XD. E-mail: rory.mitchell{at}ed.ac.uk

The vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 (VPAC₂) receptor was shown to induce both [³H]inositol phosphate ([³H]InsP)and cAMP production in transfected COS7 cells and in GH₃ cells where it is natively expressed. Neither cholera toxin nor forskolin could elicit an equivalent [³H]InsP response, suggesting independent coupling of the two pathways. The VPAC₂ receptor-mediated [³H]InsP response was partially inhibited by pertussis toxin (Ptx) and by the G-sequestering C-terminal fragment of GRK2 (GRK2-ct) in COS7 and GH₃ cells, whereas responses of control receptors were unaffected. Blockers of receptor-activated Ca²⁺ influx pathways (Co²⁺ and SKF 96365) also partially inhibited VPAC₂ receptor-mediated [³H]InsP responses. This inhibition was not present in the component of the response remaining after Ptx treatment. A range of blockers of voltage-sensitive Ca²⁺ channels were ineffective, consistent with the reported lack of these channels in COS7 cells. The data suggest that the VPAC₂ receptor may couple to phospholipase C through both Ptx-insensitive and Ptx-sensitive G proteins (G_q/11 and G_i/o, respectively) to generate [³H]InsP. In addition to G, G_i/o activation appears to require receptor-activated Ca²⁺ entry. This is consistent with the possibility that not only G_q/11-responsive and G-responsive isoforms of phospholipase C but also Ca²⁺-responsive forms may contribute to the overall [³H]InsP response.

This article has been cited by other articles:

				S.-H. Lee and C. L. Cox Excitatory Actions of Vasoactive Intestinal Peptide on Mouse Thalamocortical Neurons Are Mediated by VPAC2 Receptors J Neurophysiol, August 1, 2006; 96(2): 858 - 871. [Abstract] [Full Text] [PDF]

				W. I. DeHaven and J. Cuevas VPAC Receptor Modulation of Neuroexcitability in Intracardiac Neurons: DEPENDENCE ON INTRACELLULAR CALCIUM MOBILIZATION AND SYNERGISTIC ENHANCEMENT BY PAC1 RECEPTOR ACTIVATION J. Biol. Chem., September 24, 2004; 279(39): 40609 - 40621. [Abstract] [Full Text] [PDF]

				M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF]

				R. Mitchell, D. N. Robertson, P. J. Holland, D. Collins, E. M. Lutz, and M. S. Johnson ADP-ribosylation Factor-dependent Phospholipase D Activation by the M3 Muscarinic Receptor J. Biol. Chem., September 5, 2003; 278(36): 33818 - 33830. [Abstract] [Full Text] [PDF]

				I. Langer, P. Vertongen, J. Perret, M. Waelbroeck, and P. Robberecht A Small Sequence in the Third Intracellular Loop of the VPAC1 Receptor Is Responsible for Its Efficient Coupling to the Calcium Effector Mol. Endocrinol., May 1, 2002; 16(5): 1089 - 1096. [Abstract] [Full Text] [PDF]

				D. A. McCulloch, E. M. Lutz, M. S. Johnson, D. N. Robertson, C. J. MacKenzie, P. J. Holland, and R. Mitchell ADP-Ribosylation Factor-Dependent Phospholipase D Activation by VPAC Receptors and a PAC1 Receptor Splice Variant Mol. Pharmacol., June 1, 2001; 59(6): 1523 - 1532. [Abstract] [Full Text]